Business

How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi

Ashkenazi has been key to managing the windfall in revenue and wave of investor optimism from Eli Lilly's diabetes injection Mounjaro and obesity drug Zepbound.

adminadmin
Jun 17, 2024 - 21:00
 0  16
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Ashkenazi has been key to managing the windfall in revenue and wave of investor optimism from Eli Lilly's diabetes injection Mounjaro and obesity drug Zepbound.
Read More

Tags:

Previous Article

IRS cracks down on basis shifting by partnerships

Next Article

'Inside Out 2' hits $155 million domestic debut, second-highest animation openin...

admin
admin

Related Posts

Nuggets, Avalanche launch streaming service, with some games aired on local broadcast stations

Nuggets, Avalanche launch streaming service, with some ...

admin Sep 27, 2024  0  5

Tesla loses its EV quality edge as repair problems continue to plague the market

Tesla loses its EV quality edge as repair problems cont...

admin Jun 28, 2024  0  7

Cutting interest rates in China is irrelevant for its economy right now: Peter Boockvar

Cutting interest rates in China is irrelevant for its e...

admin Sep 20, 2024  0  13